ghk-cu endogenous levels decline with age as a multifunctional copper peptide: synthesis routes, process engineering and emerging applications Are We Ready to Measure

This is marketing framing, not evidence no clinical trial or peer-reviewed study of any such combination exists in humans

Clinical evidence shows that copper peptides: Accelerate re-epithelialisation Reduce oxidative stress Improve tissue remodelling and repair (Abdulghani et al., 1998

Explore the research behind BPC-157 & TB-500, a peptide blend studied for tissue repair, recovery, and gut health

The most efficient way for those cracks to form is in a pattern that minimizes stress across the surface, and that pattern is hexagonal

Longevity and Aging Research The decline of GHK with age has led some scientists to explore whether restoring this peptide might help support regenerative capacity in aging tissues

still under 5 mL used